Skip to content

Clinical trials

Terminated Leukemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Status: Terminated Country / region: United States Clear all

307 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
200110
20025
20039
200414
200515
200624
200726
200825
200921
201019
201114
201213
20137
201413
201515
20168
20176
20186
20199
20206
20217
20224
20236
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated307

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center54
Masonic Cancer Center, University of Minnesota22
OHSU Knight Cancer Institute9
National Cancer Institute (NCI)8
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8
Stanford University6
Bristol-Myers Squibb5
Emory University5
Fred Hutchinson Cancer Center5
H. Lee Moffitt Cancer Center and Research Institute5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia307
Leukemia, Myeloid, Acute108
Lymphoma108
Myelodysplastic Syndromes100
Precursor Cell Lymphoblastic Leukemia-Lymphoma89
Leukemia, Lymphocytic, Chronic, B-Cell76
Lymphoma, Non-Hodgkin58
Multiple Myeloma58
Hodgkin Disease43
Leukemia, Myelogenous, Chronic, BCR-ABL Positive43

Trials

Showing 1 to 25 of 307. Each trial links to its page on Pharma Observatory.

207 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.